Search

Your search keyword '"Punt, C."' showing total 783 results

Search Constraints

Start Over You searched for: Author "Punt, C." Remove constraint Author: "Punt, C."
783 results on '"Punt, C."'

Search Results

303. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR

305. Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

308. Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

311. Abstracts

313. Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.

314. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.

316. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

317. Assessment of Blood Hemodynamics by USPIO-Induced R1 Changes in MRI of Murine Colon Carcinoma.

318. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.

319. Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of...

320. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.

321. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.

322. Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study.

330. RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up.

332. Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysis.

333. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.

334. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

335. False-positive subtraction scintigram of the parathyroid glands due to metastatic tumor

336. Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer.

337. Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients

341. South Africa

343. Individual patient data (IPD) analysis of progression-free survival (PFS) versus overall survival (OS) as an endpoint for metastatic colorectal cancer (mCRC) in modern trials: Findings from the 16,700 patients (pts) ARCAD database

346. Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients.

347. Randomized Phase III Study of Capecitabine, Oxaliplatin, and Bevacizumab With or Without Cetuximab in Advanced Colorectal Cancer, the CAIRO2 Study of the Dutch Colorectal Cancer Group.

Catalog

Books, media, physical & digital resources